IFNB1 and myeloid sarcoma: Interferon beta-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human IFNB approved for high-frequency subcutaneous (sc) administration to treat MS (250 micro g, 8 million International Units [MIU] every other day [e.o.d]).